VANCOUVER, Wash. and PARIS, Jan. 10, 2025 (GLOBE NEWSWIRE) -- Absci Corporation (NASDAQ: ABSI), a data-first generative AI drug creation company, and Owkin, a TechBio that uses agentic AI to unlock complex targets for drug discovery, development, and diagnostics, today announced a partnership bringing together two leading AI platforms to rapidly discover and design novel therapeutics for patients.
Read more at globenewswire.comAbsci and Owkin Synergize Leading TechBio Platforms to Advance Generative AI Drug Discovery
ABSCI CORP
NASDAQ:ABSI (2/11/2025, 3:18:06 PM)
4.75
+0.42 (+9.7%)
ABSI Latest News and Analysis
20 days ago - ChartmillCurious about what's happening in today's session? Check out the latest stock movements and price changes.Let's have a look at the top gainers and losers one hour before the close of the markets of today's session.
20 days ago - ChartmillGapping stocks in Wednesday's sessionLet's have a look at what is happening on the US markets on Wednesday. Below you can find the gap up and gap down stocks in today's session.
